WESTFORD, Mass., July 15, 2024 /PRNewswire/ -- According to
SkyQuest, the global Active Pharmaceutical Ingredients (API)
Market size was valued at USD 210.01
Billion in 2022 and is poised to grow from USD 222.4 Billion in 2023 to USD 351.81 Billion by 2031, growing at a CAGR of
5.9% in the forecast period (2024-2031).
High investments in the research and development of novel
pharmaceutical products and high demand for novel active
pharmaceutical ingredients are also estimated to bolster market
growth. Emphasis on improving active pharmaceutical ingredients
manufacturing capabilities will create new opportunities for market
players in the future. The global active pharmaceutical ingredients
market is segmented into type, synthesis, drug, potency,
therapeutic applications, end user, and region.
Download a detailed overview:
https://www.skyquestt.com/sample-request/active-pharmaceutical-ingredients-market
Active Pharmaceutical Ingredients (API) Market
Overview:
Report
Coverage
|
Details
|
Market Revenue in
2023
|
$ 222.4
billion
|
Estimated Value by
2031
|
$ 351.81
billion
|
Growth Rate
|
Poised to grow at a
CAGR of 5.9%
|
Forecast
Period
|
2024–2031
|
Forecast
Units
|
Value (USD
Billion)
|
Report
Coverage
|
Revenue Forecast,
Competitive Landscape, Growth Factors, and Trends
|
Segments
Covered
|
Type, Synthesis, Drug,
Potency, Therapeutic Applications and End User
|
Geographies
Covered
|
North America, Europe,
Asia Pacific, Middle East & Africa, Latin America
|
Report
Highlights
|
Updated financial
information / product portfolio of players
|
Key Market
Opportunities
|
Demand for high-potency
active pharmaceutical ingredients for more effective
treatment
|
Key Market
Drivers
|
Rising prevalence of
oncology and cardiovascular indications around the world is driving
market growth as APIs are used to develop their
therapeutics
|
Segments covered in Active Pharmaceutical Ingredients
(API) Market are as follows:
- Type
- Generic APIs, and Innovative APIs
- Synthesis
- Synthetic APIs (Generic APIs, Innovative APIs), Biotech (Type
{Generic APIs and Innovative APIs}, Product {Monoclonal Antibodies,
Hormones, Cytokines, Recombinant Proteins, Therapeutic Enzymes,
Vaccines, and Blood Factors}, Expression Systems {Mammalian
Expression System, Microbial Expression System, Yeast Expression
System, Insect Expression System, Others})
- Drug
- Prescription, and Over-the-Counter Drugs (OTC)
- Potency
- Traditional APIs, and High Potency APIs
- Therapeutic applications
- Communicable Diseases, Oncology, Cardiovascular Diseases,
Orthopaedic, Cardiology, Endocrinology, Pulmonology,
Gastroenterology, Nephrology, Ophthalmology, Others
- End-User
- Pharmaceutical and Biotechnological Industry, Contact Research
Organization, Contract Manufacturing Organization, Others
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/active-pharmaceutical-ingredients-market
Low Costs of Synthetic API Manufacturing is Pushing Most
Companies Towards their Adoption
Synthetic active pharmaceutical ingredients are highly popular
and used by pharmaceutical and biotechnology companies owing to
their high affordability. High demand for generics and increasing
emphasis on improving the affordability of drugs and
pharmaceuticals are also expected to help this segment generate
rewarding business opportunities. Contract development and
manufacturing organizations and pharmaceutical manufacturing
companies are projected to lead the demand for synthetic active
pharmaceutical ingredients going forward.
Meanwhile, the demand for biotech active pharmaceutical
ingredients is forecasted to increase at a staggering CAGR across
the study period. High investments in biopharmaceutical industry
and innovation of new molecules by the same are also expected to
help this segment generate new opportunities for active
pharmaceutical ingredients companies in the long run.
High Prevalence of Cardiovascular Disorders to Promote the
Demand for Active Pharmaceutical Ingredients in Cardiovascular
Therapeutic Applications
Rising need for better security and compliance management in
commercial settings to comply with modern regulations. Commercial
active pharmaceutical ingredients are being used to manage
financial transactions and ledgers of companies to balance the
books and keep a record of receivables and payables. Management of
accounts is highly crucial for companies and commercial
organizations to optimize their business and profitability in the
future. Meanwhile, the surging demand for better oncology
treatments to manage the rising incidence of cancer cases is also
forecasted to present new opportunities for active pharmaceutical
ingredients providers in the future.
View report summary and Table of Contents
(TOC):
https://www.skyquestt.com/report/active-pharmaceutical-ingredients-market
Increasing Accessibility to Over-the-counter Drugs and
Medications to Offer Lucrative Market Growth Potential
Growing availability of generic over-the-counter (OTC)
medications around the world is projected push the demand for
active pharmaceutical ingredients over the coming years. Increasing
awareness regarding efficacy of OTC medications and their rising
adoption among the general population are also anticipated to
create new business scope for active pharmaceutical ingredients
providers through 2031.
From new to established, all active pharmaceutical ingredients
companies have equal opportunity to succeed in this market.
Collaborating with leading pharmaceutical and biotechnology
companies will be highly crucial for all active pharmaceutical
ingredients market players.
Related Reports:
Active Ingredients Market
Pharmaceuticals Market
Pharmaceutical Intermediates Market
Pharmaceutical Excipients Market
Pharmaceutical Manufacturing Market
About Us:
SkyQuest is an IP focused Research and Investment Bank and
Accelerator of Technology and assets. We provide access to
technologies, markets and finance across sectors viz. Life
Sciences, CleanTech, AgriTech, NanoTech and Information &
Communication Technology.
We work closely with innovators, inventors, innovation seekers,
entrepreneurs, companies and investors alike in leveraging external
sources of R&D. Moreover, we help them in optimizing the
economic potential of their intellectual assets. Our experiences
with innovation management and commercialization have expanded our
reach across North America,
Europe, ASEAN and Asia Pacific.
Contact:
Mr. Jagraj
Singh
SkyQuest Technology
1 Apache Way,
Westford,
Massachusetts 01886
USA (+1) 351-333-4748
Email: sales@skyquestt.com
Visit Our Website: https://www.skyquestt.com/
Logo:
https://mma.prnewswire.com/media/2446095/SkyQuest_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/active-pharmaceutical-ingredients-api-market-to-surpass-usd-351-81-billion-valuation-by-2031--high-demand-for-effective-therapeutics-and-drugs-driving-market-development--skyquest-technology-302196686.html